BREAK DOWN SILOS ACROSS DEPARTMENTS TO ACCELERATE YOUR PROMISING BIOLOGIC TO MARKET
UNIQUE PHASE-BASED FORMAT
The BPI West 2017 agenda format is designed to break down silos across multiple departments that work in the same stage of development. With four concurrent tracks focused on early stage process development through commercial manufacturing, attendees can collectively share challenges and discuss the solutions needed to improve the speed, cost and quality of biologics development.
THE MOST INNOVATIVE TECHNOLOGY
The exhibit hall gathers 80+ exhibitors representing global CMOs, CROs, suppliers and technology leaders who can fast-track your product to market. See live product demonstrations and discuss your needs with knowledgeable vendors from all over the world.
THE RIGHT PARTNERS FOR YOU
BPI West is your one-stop shop to network with global scientists and decision makers working across the entire bioprocessing spectrum. Collaborate with the innovators, suppliers, academic institutions and associations who can help you reach new heights of clinical and commercial success
Industry Experts Present Strategies for Accelerated Product Launch
New for BPI West 2017
Single-Use and Flexible Facilities Track
Hear strategies from global bioprocessing leaders on how to implement disposable and flexible facility technologies to accelerate development for multi-product pipelines, global markets and capacity optimization.
Viral Clearance & Safety Track
Apply best practices and new technologies used by industry leaders to mitigate risk, improve product quality and ensure regulatory compliance for promising biologics.
Four Single-Day Symposia
Accelerate product development by attending one of our new single-day pre-conference symposia covering continuous processing, biosimilars development, cost reduction, and cell & gene therapy production.
San Francisco Venue
Now in the heart of Downtown San Francisco, attendees will be located right in the booming biotech hub as well as world-class shopping, dining and nightlife areas.
Hilton San Francisco Union Square
333 O'Farrell Street
San Francisco, CA 94102
Phone: +1 (415) 771-1400
Only about an hour or less from the airports, this San Francisco hotel is close to shops, restaurants and entertainment venues. It's only 14 miles from San Francisco International Airport, 20 miles from Metropolitan Oakland International and 46 miles from San Jose International Airport. Discounted hotel rooms are available for BPI West 2017 attendees.
"This conference brings together leading researchers in biopharma along the entire lifecycle of products. It is an important venue for sharing of key information and moving the field forward."
Gargi Haheshwari, Ph.D.
Executive Director, Biologics Process Development & Commercialization,
"Sharing experiences helps us as individuals, but also projects, companies and the industry, ultimately leading to better drugs for patients."
Mark R.H. Krebs, Ph.D.
Senior Scientist, Technical Development
"BPI West is an ideal meeting to share experiences with industry leaders in the bioprocess field."
William N. Napoli
Scientist, BioProcess Technology and Expression, BioProcess Development
Merck & Co., Inc.
Present a Scientific Poster at BPI West 2017
Highlight your company's latest research findings by presenting a scientific poster. The deadline to submit your poster is January 27, 2017
Accelerating and streamlining downstream process development
Some estimates target the worldwide market of monoclonal antibodies (mAb) with the projected approval rate of four per year, on the order of $125 billion by 2020. Besides, several immunotherapies originated in the 1980’s, and 1990’s are to end their patents in the coming years. That is going to draw capital to the production and commercialization of biosimilars.
This whitepaper describes the current and future market drivers, present challenges and opportunities for bioprocessing upgrades. Also, it addresses the old challenges and innovative tools for mAbs, novel modalities, streamlining the interface of upstream/downstream processing, and controlling costs from bench to bedside.